DFK received research support from Cerenovus, Sensome, Neurogami Medical, Insera Therapeutics, Medtronic ... is a stockholder in Nested Knowledge, Superior Medical Experts, Marblehead Medical, and ...
Insera Therapeutics, Medtronic, Microvention, Balt, Monarch Biosciences, Brainomix, MiVi, Stryker and NIH; royalties from Medtronic; is on the DSMB of NoNO Inc and Vesalio; is a stockholder of Nested ...
Doherty’s extensive background in neuroscience research includes presiding over two FDA approvals at Sage Therapeutics and heading up various neuroscience departments at AstraZeneca. Doherty has ...
ISELIN, N.J., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United ...
After hours: February 4 at 6:46:43 PM EST Loading Chart for NTLA ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
Intensity Therapeutics, Inc. Frank Czerwiec, Chief Medical Officer, Sparrow Pharmaceuticals Nicole Kay-Mindick, Director, Clinical Operations, INmune Bio Erik Sokolowski, Senior Director ...
Figure 1 The ventricular CNS barriers in health. Cerebrospinal fluid (CSF) and the brain parenchyma are separated from the systemic blood circulation by the blood-brain barrier (BBB) and blood-CSF ...
Alcohol is one of the most widely used substances. Alcohol use accounts for 5.1% of the global disease burden, contributes substantially to societal and economic costs, and leads to approximately 3 ...
Despite the rapid expansion of effective therapeutics in RA, GC remain a common and important treatment. Although most guidelines recommend limiting use when possible to short-term bridging therapy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback